- Best-supported use: pairing 100–200 mg L-theanine with caffeine (50–100 mg) to reduce jitter and improve sustained attention on cognitive tasks — multiple RCTs and one systematic review support the combination effect (Nutritional Neuroscience, Camfield 2014).
- For acute situational stress and anxiety, small RCTs (200–400 mg) show reductions in self-rated stress and salivary cortisol response, but effects are modest and the trials are small — evidence grade is preliminary, not definitive.
- For chronic anxiety disorders (GAD, panic), evidence is insufficient — small studies exist but no guideline recommends L-theanine as monotherapy.
- Safety profile is excellent — GRAS status in the US, no serious adverse events reported at doses up to 900 mg/day for 8 weeks; well-tolerated in combination with caffeine.
- Not a sedative — it doesn't cause drowsiness at typical doses and can be taken during the day; effects on nighttime sleep are minor and inconsistent.
- Evidence grade: Moderate
L-theanine is a non-protein amino acid analog found in tea (Camellia sinensis) that has the best evidence for calm alertness and attention when paired with caffeine, weaker-but-plausible evidence for short-term stress response, and mixed evidence for anxiety or sleep. It is generally well tolerated at common supplemental doses of 100-400 mg/day, but people using blood-pressure medicines, sedatives, stimulant ADHD medication, or high-caffeine stacks should treat it as an active compound rather than “just tea.”
Table of Contents
- Evidence Summary
- What it is
- All forms & types of L-theanine
- How it works
- What works & what doesn't
- Benefits with evidence grades
- Risks & all side effects
- All interactions
- Who should avoid it
- Dosage & how to take
- Frequently Asked Questions
- Trust & disclosure
Evidence Summary
| Claim | Evidence | Source | Funding / conflict / country | Strength |
|---|---|---|---|---|
| Relaxation without drowsiness via alpha activity | Acute EEG/MEG studies show increased alpha-band activity after 200 mg L-theanine or an L-theanine-based drink, but many data are small and industry-linked. | Evans et al., 2021; White et al., 2016 | Ethical Naturals/KGK, USA/Canada; Neurobrands grant, Australia/USA | Moderate for alpha waves; weak for clinical calm |
| Stress response | Small acute and 4-week studies report lower tension-anxiety, lower stress-response blood pressure in high responders, or improved stress-related symptoms. | Yoto et al., 2012; Kimura et al., 2007; Hidese et al., 2019 | Yoto: Japanese public funding, no conflicts; Kimura: funding not stated, Japan; Hidese: Taiyo-funded, Japan | Moderate-low |
| Anxiety reduction | Healthy-adult stress studies are promising, but an 8-week adjunctive GAD trial did not beat placebo on anxiety. | Sarris et al., 2019; Hidese et al., 2019 | Sarris: Australia, funding not shown on PubMed; Hidese: Taiyo-funded, Japan | Weak / mixed |
| Attention and focus with caffeine | Multiple acute trials and a systematic review report faster attention switching, better alertness, and improved attention outcomes with L-theanine plus caffeine. | Owen et al., 2008; Haskell et al., 2008; Sohail et al., 2021 | Owen: Unilever R&D, UK; Haskell: funding not shown on PubMed, UK; Sohail: no competing interests, funding not stated | Moderate-strong for acute tasks |
| Sleep quality | ADHD boys had improved actigraphy sleep efficiency at 400 mg/day, while GAD adults improved sleep satisfaction but not anxiety, and a 2024 review found sleep results inconsistent. | Lyon et al., 2011; Sarris et al., 2019; Moshfeghinia et al., 2024 | Lyon: Taiyo-affiliated authors, Canada/Japan; Sarris: Australia; review: Iran/Australia, no competing interests | Weak / mixed |
| Schizophrenia adjunct | Small adjunctive trials reported reduced positive, activation, and anxiety symptoms at 400 mg/day with antipsychotics, but evidence is not enough for self-treatment. | Ritsner et al., 2011; Moshfeghinia et al., 2024 | Ritsner: Israel, funding not shown on PubMed; review: no competing interests | Low / specialist-only |
| Safety at common doses | Human trials generally report good tolerability, but mild GI symptoms, headache, dry mouth, metallic taste, dizziness-like symptoms, appetite change, or rare individual events can occur. | Moulin et al., 2024; Moshfeghinia et al., 2024; Lyon et al., 2011 | Mixed: Ethical Naturals-funded; independent review; Taiyo-linked ADHD trial | Moderate for short-term tolerability |
What it is
L-theanine is a water-soluble, non-protein amino acid also known as N-ethyl-L-glutamine or L-glutamic acid-γ-monoethylamide, and FDA GRAS Notice 000209 describes it as naturally occurring in tea (Camellia sinensis) and a non-edible mushroom (Xerocomus badius) (FDA GRN 000209 / Suntheanine PDF). A 2022 review describes L-theanine as a unique free amino acid and secondary metabolite in tea that is widely distributed in tea plant parts, with production first occurring in roots before transport to shoots (Frontiers in Nutrition review).
The “L” matters because theanine is chiral: L-theanine and D-theanine are mirror-image enantiomers, while DL-theanine is a racemic mixture containing both forms. In a rat pharmacokinetic study, D-theanine had much lower gut absorption than L-theanine after oral administration, and D,L-theanine behaved differently from either pure enantiomer (Desai et al., 2005).
The active compound — what actually does the work
The supplement evidence is about L-theanine, not generic “tea amino acids.” FDA’s Taiyo GRAS notice defines the commercial food ingredient as L-theanine up to 250 mg per serving in several food categories (FDA GRAS Notice No. GRN 209).
All forms & types of L-theanine
| Form/type | Source/manufacture | Bioavailability / evidence issue | Best for | Cost tendency | Verdict |
|---|---|---|---|---|---|
| L-theanine | Pure L-enantiomer; may be extracted, synthesized, or enzymatically produced. | Human trials largely use L-theanine; common studied doses are 100-400 mg/day. | General calm-focus products; caffeine stacks; stress-response formulations. | — | Preferred baseline form: choose labels that clearly say L-theanine and state milligrams per serving. |
| Suntheanine® | Taiyo/Kagaku patented branded L-theanine; GRAS dossier says it is made from food-grade L-glutamine and ethylamine using glutaminase enzymes from immobilized microorganisms (Suntheanine GRAS PDF). | Used in several trials; one older-adult RCT used Suntheanine containing ≥98% L-theanine (Baba et al., 2021). | Brands wanting a traceable, enantiopure ingredient and FDA GRAS history. | Usually premium versus generic L-theanine; imported Suntheanine products may be costly. | Good ingredient traceability, but conflicts matter: many positive studies involve Taiyo employees, Taiyo funding, or Taiyo-supplied material. |
| D-theanine | D-enantiomer; may appear as a contaminant or in racemic material. | Rat data show much lower oral gut absorption than L-theanine and preferential excretion (Desai et al., 2005). | No established consumer benefit. | Not usually sold as a standalone nootropic . | Avoid as a benefit claim: human efficacy evidence is lacking. |
| Racemic DL-theanine | Mixture of L- and D-theanine, often a chemical-synthesis risk when enantiomeric purity is not controlled. | D,L-theanine was not bioequivalent to pure L-theanine in rat pharmacokinetics and can reduce plasma concentrations through enantiomer competition (Desai et al., 2005). | Only acceptable if a product has third-party data proving high L-enantiomer content. | May be cheaper if purity is lower or unstated. | Downgrade: avoid labels that say “theanine” without specifying L-theanine. |
| Green-tea-extract-derived L-theanine | Extracted or enriched from tea leaves, decaffeinated tea, tea powder, or tea fractions. | Can co-deliver catechins and caffeine; green tea extract safety cannot be assumed to equal pure L-theanine safety. | Food/beverage applications or tea-native positioning. | Variable; often part of “green tea extract” blends rather than pure L-theanine capsules. | Use carefully: check caffeine, catechin/EGCG dose, liver warnings, and standardization. |
| Synthetic or chemically synthesized L-theanine | FDA GRN 501 covers chemically synthesized L-theanine from Zhejiang Tianrui Chemical Co., Ltd. in China (FDA GRAS Notice 501). | Potentially equivalent if it is verified as L-enantiomer with low D-theanine and impurity levels. | Lower-cost supplement production when purity testing is strong. | Often used in generic products; price varies with testing and brand trust. | Acceptable only with purity documentation: synthetic is not automatically inferior, but enantiomeric purity is the key. |
Original insight: the cheapest “theanine” is not always the cheapest effective L-theanine
A 200 mg label claim is only useful if the ingredient is truly L-theanine and not an unspecified racemate. The form decision should prioritize (1) L-enantiomer clarity, (2) third-party testing or branded ingredient documentation, (3) caffeine/catechin disclosure if tea-extract-derived, and (4) cost per verified 100 mg L-theanine rather than cost per capsule.
How it works
L-theanine is structurally related to glutamate and glutamine, and early human stress research describes it as blocking L-glutamic acid binding to glutamate receptors in the brain (Kimura et al., 2007). The practical effect is not a benzodiazepine-like sedation; it is better described as dampening arousal signals while preserving alertness, which fits the repeated finding that L-theanine pairs unusually well with caffeine in attention tasks (Haskell et al., 2008; Owen et al., 2008).
What the body does with it
Human trials typically test acute doses around 100-250 mg or daily doses around 200-400 mg, with effects often measured 30 minutes to 3 hours after ingestion for acute cognition and stress outcomes (Owen et al., 2008; Yoto et al., 2012; Evans et al., 2021). In animal pharmacokinetics, the L- and D-forms behaved differently after oral dosing, so purity is not a cosmetic label detail; it may change exposure (Desai et al., 2005).
Why form and delivery matter
Pure L-theanine isolates let users control caffeine separately, while green tea extracts and nootropic energy stacks may add caffeine, catechins, adaptogens, sedatives, or stimulants. NIH/NCCIH states that green tea contains caffeine, green tea extract supplements can cause nausea, constipation, abdominal discomfort, and increased blood pressure, and liver injury has been reported mainly with green tea extracts in tablets or capsules (NIH NCCIH Green Tea).
What works & what doesn't
| Claimed benefit | Verdict | Evidence grade | Evidence | Key caveat |
|---|---|---|---|---|
| Relaxation without drowsiness / alpha-wave increase | WORKS for alpha-wave signal; MIXED for felt relaxation | Moderate for EEG/alpha, weak-moderate clinically | 200 mg AlphaWave increased frontal alpha power at 3 hours, and an L-theanine drink showed trends in posterior alpha especially in high-trait-anxiety participants (Evans et al., 2021; White et al., 2016). | Alpha waves are a biomarker, not a guaranteed calmness outcome. |
| Anxiety reduction | MIXED | Weak | A 46-person GAD trial found L-theanine did not outperform placebo on anxiety (HAMA p = 0.73), while some healthy-adult trials report lower tension-anxiety or stress-related symptoms (Sarris et al., 2019; Yoto et al., 2012; Hidese et al., 2019). | Do not market as an anxiety treatment. |
| Sleep quality | MIXED | Weak-moderate in ADHD boys; weak in general adults | 400 mg/day improved actigraphy sleep efficiency in boys with ADHD, while GAD adults improved sleep satisfaction but not insomnia severity, and a 2024 review found no significant placebo separation in one sleep-disorder study (Lyon et al., 2011; Sarris et al., 2019; Moshfeghinia et al., 2024). | It may improve sleep indirectly by reducing arousal, not by acting like a hypnotic. |
| Attention/focus with caffeine | WORKS | Moderate-strong for acute cognitive tasks | 100 mg L-theanine + 50 mg caffeine improved speed and accuracy on attention switching, and 250 mg L-theanine + 150 mg caffeine improved multiple attention and mood outcomes in acute trials (Owen et al., 2008; Haskell et al., 2008). | Benefits are task-specific and do not erase caffeine overuse, sleep debt, or anxiety sensitivity. |
| Cognitive performance without caffeine | MIXED | Weak-moderate | Older-adult data found acute attention and working-memory-task improvements with 100.6 mg Suntheanine, but no effect on several memory, face-recognition, visual processing, or motor tasks (Baba et al., 2021). | Best evidence is attention under demand, not broad “memory enhancement.” |
| Stress response | MIXED | Moderate-low | 200 mg L-theanine attenuated blood-pressure increases during mental tasks in high stress responders, and 200 mg/day for 4 weeks improved several stress-related measures in a Taiyo-funded trial (Yoto et al., 2012; Hidese et al., 2019). | Stress results are stronger in selected responders or industry-funded trials than in broad independent replication. |
| Schizophrenia adjunct | INSUFFICIENT EVIDENCE for consumer use; specialist-only adjunct evidence | Low | An 8-week adjunctive trial reported reduced anxiety and positive/general psychopathology at 400 mg/day with antipsychotics, but the study was small and should not guide self-treatment (Ritsner et al., 2011; Moshfeghinia et al., 2024). | Psychosis treatment changes require psychiatric supervision. |
Benefits by claim
1. Calm alertness and alpha-wave activity — Grade: Moderate for biomarker, weak-moderate clinically
The strongest “relaxation without drowsiness” claim is not that L-theanine makes everyone feel tranquil; it is that acute L-theanine can increase alpha-band brain activity, a pattern commonly associated with relaxed wakefulness. In a 2021 triple-blind crossover study, a single 200 mg dose of AlphaWave L-theanine increased frontal alpha power versus placebo at 3 hours during eyes-open testing, but the study had only 16 randomized participants and was funded by Ethical Naturals (Evans et al., 2021).
White et al. tested a 200 mg L-theanine-based drink and found reduced subjective stress response 1 hour after dosing, lower cortisol response at 3 hours, and an MEG alpha pattern that was suggestive but not uniformly statistically significant after correction (White et al., 2016). The funder was Neurobrands, and the product included alpha-GPC, phosphatidylserine, and chamomile in addition to L-theanine, so it should not be treated as a clean L-theanine-only trial (White et al., 2016).
2. Caffeine synergy for focus — Grade: Moderate-strong
The caffeine + L-theanine stack has better evidence than L-theanine alone for acute cognitive performance. Owen et al. found that 100 mg L-theanine plus 50 mg caffeine improved both speed and accuracy on an attention-switching task and reduced distraction during memory testing in 27 healthy volunteers (Owen et al., 2008). Haskell et al. found that 250 mg L-theanine plus 150 mg caffeine improved rapid visual information processing accuracy, mental fatigue, simple reaction time, numeric working-memory reaction time, sentence verification accuracy, and alertness-related ratings versus placebo or single ingredients on several tasks (Haskell et al., 2008).
The mechanism is likely two-sided: caffeine increases alertness through adenosine antagonism, while L-theanine may soften caffeine’s edge through glutamate/GABA-related and alpha-wave pathways. The limit is also clear: a theanine-caffeine stack does not make high caffeine harmless, and NIH/NCCIH flags caffeine-related cautions for green tea, pregnancy, lactation, and medicine interactions (NIH NCCIH Green Tea).
3. Stress physiology — Grade: Moderate-low
Yoto et al. used a randomized crossover design in 14 analyzed healthy students and found that 200 mg L-theanine significantly inhibited blood-pressure increases during mental arithmetic in participants who were high blood-pressure responders to stress, but it did not reduce the blood-pressure rise during cold-pressor physical stress (Yoto et al., 2012). This makes the effect narrower than “lowers blood pressure”: the best wording is “may blunt some mental-stress blood-pressure responses in high responders.”
Kimura et al. studied 12 participants and reported reduced heart-rate and salivary IgA stress responses after L-theanine versus placebo during a mental arithmetic stressor, but PubMed does not state the dose, funding, or conflict disclosures (Kimura et al., 2007). Hidese et al. tested 200 mg/day for four weeks and reported lower depression, trait-anxiety, and sleep-quality scores in a 30-person crossover RCT, but the study was funded by Taiyo Kagaku and two authors were Taiyo employees who supplied the L-theanine and placebo tablets (Hidese et al., 2019).
4. Anxiety — Grade: Weak / mixed
L-theanine is not well proven as an anxiety treatment. The most clinically relevant GAD study tested 450-900 mg adjunctive L-theanine in 46 adults on stable antidepressants and found no advantage over placebo for anxiety on the Hamilton Anxiety scale (p = 0.73) (Sarris et al., 2019).
The better-supported anxiety-related use is situational stress or tension in otherwise healthy adults. That distinction matters for compliant health writing: “supports calm focus under stress” is closer to the evidence than “treats anxiety disorder.”
5. Sleep quality — Grade: Weak-moderate in ADHD boys; weak in general adults
Lyon et al. tested 400 mg/day Suntheanine in boys aged 8-12 with ADHD and found improved actigraphy-measured sleep efficiency and fewer nocturnal activity bouts versus placebo, with no significant effect on sleep latency or sleep duration (Lyon et al., 2011). The study included Taiyo Kagaku-affiliated authors and did not provide a clear funding/conflict statement in the available PDF, so the sleep result should be treated as promising but not independent.
In GAD adults, Sarris et al. found improved self-reported sleep satisfaction but not insomnia severity or anxiety, suggesting that L-theanine may help subjective sleep comfort in some people without being a reliable insomnia therapy (Sarris et al., 2019). A 2024 mental-disorders systematic review concluded that a sleep-problem study found no statistically significant difference between L-theanine and placebo, reinforcing the mixed verdict (Moshfeghinia et al., 2024).
6. Schizophrenia adjunct — Grade: Low / specialist-only
Ritsner et al. tested 400 mg/day L-theanine added to antipsychotic treatment in schizophrenia or schizoaffective disorder and reported reductions in anxiety and positive/general psychopathology, while negative symptoms, neurocognitive task scores, side effects, quality of life, and functioning were not affected (Ritsner et al., 2011). The trial had 60 participants enrolled but only 40 completed the protocol, and PubMed does not show funding or conflict disclosures, so it is not enough for consumer self-use claims (Ritsner et al., 2011).
Independent evidence investigation: funding, conflicts, and country
| Source | Country / institution | Funding and conflict trace | Independence rating | Credibility rank | How used |
|---|---|---|---|---|---|
| Yoto et al., 2012 | Japan; University of Shizuoka | CREATE, JST, JSPS/MEXT public funding; authors declare no competing interests. | Independent | Strong for acute stress physiology; small sample | BP/stress-response claim |
| Kimura et al., 2007 | Japan; Nagoya University | Funding/conflicts not shown on PubMed; one author, Lekh Raj Juneja, has Taiyo/Kagaku industry history in the field. | Unclear / possible industry influence | Moderate-low | Supportive acute stress signal only |
| Hidese et al., 2019 | Japan; National Center of Neurology and Psychiatry / Taiyo Kagaku | Explicitly funded by Taiyo Kagaku; Yasukawa and Ozeki were Taiyo employees who supplied tablets. | Conflicted | Moderate method, high influence risk | Included but downgraded |
| Evans et al., 2021 | Canada; KGK Science; Ethical Naturals USA | Funded by Ethical Naturals; one author employed by Ethical Naturals and others by KGK Science. | Conflicted | Moderate method, high influence risk | Alpha-wave evidence, downgraded |
| Moulin et al., 2024 | Canada; KGK Science; Ethical Naturals USA | Funded by Ethical Naturals; Ethical Naturals employee and KGK employees among authors. | Conflicted | Moderate-low for efficacy; useful for AE reporting | Safety and stress limitations |
| White et al., 2016 | Australia; Swinburne University; product company in USA | Funded by Neurobrands; funder stated to have no design/conduct/interpretation input. | Conflicted but transparent | Moderate | Combination drink stress/MEG evidence |
| Owen et al., 2008 | UK; Unilever R&D | Authors affiliated with Unilever Research and Development; funding not shown on PubMed. | Conflicted / industry-affiliated | Moderate | Caffeine synergy, downgraded |
| Haskell et al., 2008 | UK; Northumbria University | Funding/conflicts not shown on PubMed. | Unclear | Moderate | Caffeine synergy |
| Kahathuduwa et al., 2020 | USA; Texas Tech University Health Sciences Center | Texas Tech seed and faculty research funding; authors declare no competing interests. | Independent | Moderate for mechanistic ADHD signal; very small sample | ADHD/caffeine interaction caution |
| Lyon et al., 2011 | Canada / Japan; UBC, Canadian Centre for Functional Medicine, Taiyo Kagaku | No clear funding statement in PDF; two authors affiliated with Taiyo Kagaku. | Conflicted / unclear funding | Moderate-low | Sleep in ADHD boys, downgraded |
| Sarris et al., 2019 | Australia; Western Sydney University / University of Melbourne / University of Queensland | PubMed lists non-U.S. government support but does not show detailed conflicts. | Probably independent / incomplete disclosure in PubMed | Strong for anxiety non-effect; moderate overall | GAD anxiety and sleep satisfaction |
| Ritsner et al., 2011 | Israel; Technion/Rappaport Faculty of Medicine | Funding/conflicts not shown on PubMed; Stanley Medical Research Institute lists related grant support for the trial program (Stanley Medical Research Institute). | Unclear / nonprofit grant context | Moderate-low | Schizophrenia adjunct, specialist-only |
| Moshfeghinia et al., 2024 | Iran / Australia; Shiraz University and Curtin University affiliations | Funding: not applicable; authors declare no competing interests. | Independent | Strong as a map; limited by included studies | Mental-health synthesis |
Money-trail summary: the most consumer-friendly claims — relaxation, stress, sleep, and branded ingredient quality — rely heavily on Taiyo/Kagaku/Suntheanine or other ingredient-brand studies. Independent evidence is strongest for acute stress physiology from Japan and the tiny ADHD caffeine-theanine study from Texas Tech, but the evidence base still needs larger, preregistered, non-industry trials.
Risks & all side effects
L-theanine is generally well tolerated in short human trials, but “well tolerated” does not mean side-effect-free. The 2024 AlphaWave 400 mg/day trial reported nine adverse events in six participants; two mild events in the L-theanine group — metallic taste and dry mouth — were classified as possibly related to the investigational product, while other events included abdominal distension, decreased appetite, fatigue, insomnia, sore throat, and toe injury, mostly considered unrelated or unlikely related (Moulin et al., 2024).
| Side effect / safety issue | Frequency signal | Dose relationship | What to do | Evidence |
|---|---|---|---|---|
| GI discomfort, abdominal pain, nausea, diarrhea, constipation, bloating | Uncommon in L-theanine-only trials; reported in psychiatric adjunct trials and one AlphaWave participant had mild abdominal distension judged unlikely related. | More likely at higher total daily doses or in combination with SSRIs/antipsychotics or other supplements. | Take with food; stop and reassess if persistent. | Moulin et al., 2024; Moshfeghinia et al., 2024 |
| Headache | Haskell et al. found 250 mg L-theanine alone increased “headache” ratings, while the caffeine + L-theanine combination reduced “headache” and “tired” ratings in that study. | May occur with acute higher doses, dehydration, caffeine withdrawal, or caffeine mismatch. | Reduce dose; separate from caffeine changes. | Haskell et al., 2008 |
| Dizziness or light-headedness | Not consistently reported in RCTs, but plausible when L-theanine is combined with blood-pressure-lowering drugs or when stress-BP responses are blunted. | Risk likely rises with antihypertensives, alcohol, dehydration, or higher doses. | Monitor blood pressure and avoid driving if light-headed. | Yoto et al., 2012 |
| Dry mouth / metallic taste | Two mild, possibly related events in the 2024 400 mg/day AlphaWave trial. | Observed at 400 mg/day in divided dosing. | Usually self-limited; stop if bothersome. | Moulin et al., 2024 |
| Insomnia or overstimulation | Pure L-theanine is not usually stimulating, but one insomnia event occurred in the AlphaWave group and caffeine stacks can disturb sleep. | Mainly depends on caffeine timing and sensitivity, not L-theanine alone. | Avoid caffeine stacks after early afternoon; use standalone L-theanine if sleep is the goal. | Moulin et al., 2024; NIH NCCIH Green Tea |
| Facial tic in a child | One boy with a prior tic history developed a subtle facial tic after starting 400 mg/day; investigator judged it unlikely related and it ceased after discontinuation. | Observed in a pediatric ADHD trial; pediatric use should be clinician-supervised. | Stop and consult a clinician if tics, agitation, or behavior changes occur. | Lyon et al., 2011 |
| Green-tea-extract risks | Not a pure L-theanine issue, but relevant if the label uses green tea extract as the source. | Higher EGCG/catechin extracts, fasting use, and susceptible genetics may raise liver-risk concern. | Do not equate green tea extract capsules with pure L-theanine capsules. | NIH NCCIH Green Tea |
The caffeine-L-theanine synergy and its limits
The common “200 mg L-theanine + 100 mg caffeine” nootropic ratio is a practical extrapolation from trials using ratios around 2:1 L-theanine:caffeine, such as 100 mg L-theanine + 50 mg caffeine and 250 mg L-theanine + 150 mg caffeine (Owen et al., 2008; Haskell et al., 2008). The limit is that L-theanine may smooth the subjective feel of caffeine, but it does not remove caffeine’s effects on sleep, heart rate, anxiety sensitivity, pregnancy/lactation exposure, or interactions with medicines (NIH NCCIH Green Tea).
All interactions
| Interacts with | Severity | Mechanism | Action | Evidence quality |
|---|---|---|---|---|
| Stimulants / caffeine: coffee, tea, energy drinks, caffeine tablets, pre-workouts | Moderate — use intentionally | L-theanine may improve attention and reduce tired/headache ratings when combined with caffeine, while caffeine still acts as a stimulant and can disturb sleep or worsen palpitations/anxiety in sensitive users. | Start around 100-200 mg L-theanine with 50-100 mg caffeine; avoid late-day use; cap total caffeine according to personal and medical limits. | Human RCTs and systematic review (Owen et al., 2008; Haskell et al., 2008; Sohail et al., 2021). |
| Blood-pressure medications: ACE inhibitors, ARBs, beta-blockers, calcium-channel blockers, diuretics, nitrates, alpha-blockers; also antihypertensive herbs | Caution — monitor | L-theanine attenuated mental-stress blood-pressure increases in high responders, creating a plausible additive hypotensive or light-headedness effect with antihypertensives. | Check sitting/standing BP when starting; use clinician guidance if taking multiple BP drugs, nitrates, or if prone to fainting. | Human stress-BP RCT, indirect for drug interaction (Yoto et al., 2012). |
| Sedatives / CNS depressants: benzodiazepines, Z-drugs, barbiturates, sedating antihistamines, opioids, alcohol, gabapentinoids, melatonin/GABA-heavy sleep stacks | Caution — additive calming/drowsiness possible | L-theanine is not a strong sedative, but it is used for relaxation and sleep satisfaction, so additive psychomotor slowing is plausible when combined with sedatives or alcohol. | Avoid alcohol-sedative-L-theanine stacking; do not drive or operate machinery until individual response is known. | Mechanistic/clinical plausibility from sleep and stress trials; direct drug-interaction RCTs lacking (Sarris et al., 2019; Lyon et al., 2011). |
| Stimulant ADHD medicines: methylphenidate, dexmethylphenidate, amphetamine salts, lisdexamfetamine; atomoxetine/modafinil-like wakefulness drugs as adjacent caution | Caution — clinician-supervised in children | Evidence is too small to prove safety with stimulants; caffeine-theanine can alter attention/inhibition measures and caffeine may add cardiovascular or sleep burden to stimulant treatment. | Do not add caffeine-theanine stacks to a child’s ADHD regimen without the prescriber; monitor appetite, sleep, tics, heart rate, and blood pressure. | One tiny ADHD crossover RCT reported no complaints suggesting L-theanine/caffeine interaction with methylphenidate in its sample, and the sleep RCT stratified randomization by stimulant use (Kahathuduwa et al., 2020; Lyon et al., 2011). |
| Antidepressants / antipsychotics: SSRIs, SNRIs, fluvoxamine, sertraline, risperidone, other antipsychotics | Caution — adjunct use only with clinician | Some trials combine L-theanine with antidepressants or antipsychotics, but those are medical adjunct studies, not proof that unsupervised stacking is safe for every psychiatric regimen. | Do not use L-theanine to replace prescribed psychiatric medication; tell the prescriber if adding it. | Mental-disorders systematic review and schizophrenia/GAD trials (Moshfeghinia et al., 2024; Ritsner et al., 2011; Sarris et al., 2019). |
| Green tea extract-specific interactions: nadolol, atorvastatin, raloxifene, other medicines | Potentially significant for extracts | Green tea extract includes catechins and caffeine, not just L-theanine; NIH/NCCIH reports reduced nadolol blood levels and interactions with atorvastatin and raloxifene. | Choose pure L-theanine if avoiding green tea extract interactions; ask a clinician before green tea extract capsules if on medicines. | NIH/NCCIH safety page (NIH NCCIH Green Tea). |
Who should avoid it
Avoid or use only with clinician guidance if pregnant or breastfeeding, because the safety question is often about caffeine-containing tea or stacks rather than pure L-theanine, and NIH/NCCIH recommends pregnancy and breastfeeding caution for caffeine exposure from green tea (NIH NCCIH Green Tea). Children should not use L-theanine, especially caffeine-theanine stacks, without a pediatric clinician; pediatric data are mostly ADHD boys under research conditions and include one facial-tic event in a child with prior tics (Lyon et al., 2011).
People with low blood pressure, fainting tendencies, or multiple antihypertensive medications should monitor BP because L-theanine attenuated mental-stress blood-pressure increases in high responders (Yoto et al., 2012). People with liver disease or those using hepatotoxic medicines should avoid green-tea-extract-derived products unless medically supervised, because NCCIH reports uncommon liver injury mainly with green tea extracts in tablets or capsules (NIH NCCIH Green Tea).
Dosage & how to take
| Goal | Typical evidence-matched dose | Timing | Form preference | Evidence caveat |
|---|---|---|---|---|
| Calm focus with caffeine | 100-200 mg L-theanine with 50-100 mg caffeine | Morning or early afternoon | Pure L-theanine capsule + known caffeine source | Trials used 100 mg + 50 mg and 250 mg + 150 mg; avoid high-caffeine escalation (Owen et al., 2008; Haskell et al., 2008). |
| Situational stress | 200 mg L-theanine | 30-60 minutes before a stressor or during high-demand work | L-theanine or Suntheanine | BP/stress findings are strongest in high responders and small samples (Yoto et al., 2012). |
| Sleep support without caffeine | 100-200 mg in adults as a conservative starting range | 30-60 minutes before bed | Pure L-theanine, not caffeine stack | Sleep evidence is mixed; ADHD child trial used 400 mg/day under supervision (Lyon et al., 2011). |
| Research-level psychiatric adjunct | 400 mg/day in divided doses in schizophrenia studies; 450-900 mg in GAD trial | Only under clinician guidance | Pharmaceutical-like monitoring | Not appropriate for self-treatment or product claims (Ritsner et al., 2011; Sarris et al., 2019). |
Practical Pure City dosing view: for healthy adults, start at 100 mg L-theanine; move to 200 mg only if needed; use caffeine stacks only when the goal is focus, not sleep; and avoid exceeding local label directions or (https://pubmed.ncbi.nlm.nih.gov/18681988/); Haskell et al., 2008). Evidence is weaker or mixed for anxiety disorders, general insomnia, and broad memory enhancement (Sarris et al., 2019; Baba et al., 2021).
Is L-theanine safe to take every day?
Short-term trials generally find L-theanine well tolerated at 100-400 mg/day, with mild possible side effects such as dry mouth, metallic taste, GI discomfort, headache, appetite change, or sleep disturbance in some participants (Moulin et al., 2024; Moshfeghinia et al., 2024). Long-term independent safety data are thinner than short-term tolerability data, so daily use should stay conservative and should be reviewed if medications are involved.
What is the best L-theanine dose for focus?
A practical focus dose is 100-200 mg L-theanine with 50-100 mg caffeine in the morning or early afternoon. This matches trial ratios such as 100 mg L-theanine + 50 mg caffeine and 250 mg L-theanine + 150 mg caffeine, while keeping caffeine exposure more conservative than many energy products (Owen et al., 2008; Haskell et al., 2008).
Does L-theanine help anxiety?
L-theanine may help situational stress or tension in some healthy adults, but it did not outperform placebo for anxiety symptoms in a 46-person generalized anxiety disorder trial using adjunctive 450-900 mg doses (Sarris et al., 2019). It should not be marketed as a treatment for anxiety disorder.
Does L-theanine help sleep?
The sleep evidence is mixed: 400 mg/day Suntheanine improved actigraphy sleep efficiency in boys with ADHD, while GAD adults mainly reported better sleep satisfaction and a 2024 review found inconsistent placebo separation across sleep-related studies (Lyon et al., 2011; Sarris et al., 2019; Moshfeghinia et al., 2024). If sleep is the goal, use pure L-theanine without caffeine.
Is Suntheanine better than regular L-theanine?
Suntheanine is a traceable branded L-theanine made enzymatically from L-glutamine and ethylamine, and FDA had no questions on Taiyo’s GRAS conclusion for L-theanine up to 250 mg per serving in specified foods (Suntheanine GRAS PDF; FDA GRAS Notice 209). It is not automatically more effective than any verified pure L-theanine, and many Suntheanine-linked studies have Taiyo funding or Taiyo employee involvement, so claims should be evidence-graded with that conflict disclosed (Hidese et al., 2019; Baba et al., 2021).
Can I take L-theanine with ADHD medication?
Do not add L-theanine-caffeine stacks to ADHD stimulant medication without the prescriber, especially for children. A tiny ADHD crossover RCT reported no complaints suggesting interaction with methylphenidate in its small sample, but it had only five completers and is not enough to prove broad safety (Kahathuduwa et al., 2020).
What should Indian consumers check on the label?
Indian consumers should check that the label says L-theanine, not vague “theanine,” gives the dose per serving, avoids unlisted caffeine if the goal is sleep, and stays within the FDA GRAS-cleared serving range (up to 250 mg per serving). Products using green tea extract should also disclose caffeine and catechin/EGCG content because NIH/NCCIH warns that green tea extracts have a different safety and interaction profile than beverage tea or pure L-theanine (NIH NCCIH Green Tea).
Related research
For deeper, evidence-graded context on the conditions L-theanine is most often used for, see Pure City Research's condition guides:
- Stress, anxiety & depression: prevention and management guide
- Sleep: prevention and management guide
Trust & disclosure
Frequently asked questions
Does L-theanine actually calm you down?
Modestly, in small RCTs at 200–400 mg. It's not comparable to a benzodiazepine or SSRI — think "takes the edge off caffeine jitter and acute stress," not "treats an anxiety disorder." No major guideline recommends it for clinical anxiety (L-theanine RCT review, Nutrients).
What's the best L-theanine + caffeine ratio?
The most-studied ratio is roughly 2:1 L-theanine to caffeine — e.g., 100 mg L-theanine + 50 mg caffeine, or 200 mg + 100 mg. Studies show improved sustained attention and reduced mind-wandering versus caffeine alone. A cup of green tea has roughly this ratio naturally (Camfield systematic review, Nutritional Neuroscience).
Is L-theanine safe?
Yes, in the doses that have been studied. It has GRAS (Generally Recognized As Safe) status in the US and no serious adverse events have been reported at doses up to 900 mg/day for 8 weeks. It doesn't interact meaningfully with common medications, though anyone on blood-pressure medication should note that very high doses may lower blood pressure slightly (L-theanine safety summary).
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.